Heads

  • Blanca Cárdaba Olombrada (Principal Investigator)
  • Javier Cuesta Herranz (Principal Investigator, Head of RETIC RIRAAF)
  • Victoria del Pozo Abejón (Head of CIBERES)
  • Joaquín Sastre Domínguez
  • Fernando Vivanco Martínez

Research staff

  • Gloria Álvarez Llamas (IP proyecto)
  • Manuel de las Heras Gonzalo
  • Mar Fernández Nieto
  • Rosa García Delgado
  • Carlos Pastor Vargas

Trainee staff

  • Selene Baos Miniz
  • David Calzada Ricote
  • Laura González Calero
  • Marta Martín Lorenzo
  • Carla Silvana Mazzeo
  • Jose Antonio Cañas

Technical staff and assistants

  • Aroa Sanz Maroto
  • Verónica Sanz Serrano

Staff Research Associates

  • Pilar Gajate Fernández. Hospital Universitario Rey Juan Carlos
  • Ricardo Moreno Borque. Hospital Universitario Rey Juan Carlos
  • Javier Ruiz Hornillos. Hospital Universitario Infanta Elena
  • Eva Vaquerizo García. Hospital Universitario Rey Juan Carlos

Main lines of research


Allergic asthma: Molecular profile, immunoregulation and epigenetic analysis


The main objective of this project is the characterization and validation of discriminatory molecular biomarkers (diagnostic biomarkers) in allergic asthma, and the study of the regulatory mechanisms (therapeutic targets) involved through the analysis of immunology, gene expression, protein expression, and epigenetic mechanisms (methylation).

* Principal Investigator: Blanca Cárdaba


Allergic response, asthma, and eosinophilic inflammation


Asthma is a highly prevalent disease in industrialized countries that accounts for a significant proportion of healthcare resources. An estimated 300 million people are currently affected, and this figure is expected to increase further in the next 50 years, largely due to current lifestyles. This line of research aims to unravel the mechanisms underlying the genesis and evolution of asthma, and to develop diagnostic and prognostic biomarkers.

* Principal Investigator: Victoria del Pozo


Food allergy: Study of phenotypes of allergic patients, identification and characterization of new food allergens, and the study of associated molecular patterns.


Development of new methods for identifying hidden allergens by mass spectrometry.

* Principal Investigator: Javier Cuesta Herranz


Identification of markers of cardiovascular disease through "omics" analysis and characterization of atherosclerotic lesions through mass spectrometry image analysis.

Principal Investigator: Fernando Vivanco Martínez

foto2 alergiaHigh resolution image. This link will open using lightbox, there may be a context switch







Omics approaches to hypertension, chronic kidney disease, and acute kidney injury in the search for specific molecular fingerprints. Identification of specific markers of cardiovascular risk.

* Principal Investigator: Gloria Álvarez-Llamas


Identification and characterization of new food allergens and the study of their prevalence and relevance in the Spanish population.

* Principal Investigator: Javier Cuesta Herranz


Development of new methods for identifying hidden allergens by mass spectrometry.

* Principal Investigator: Carlos Pastor-Vargas


Publications (2014)


Total number of Publications

Nº of Publications with IF

Accumulated IF

Average

IF

Nº of Publications (Q1)

(%) Q1

38

32

117,96

3,69

13

40,63%


1.

Moscato G Pala G Cullinan P Folletti I Gerth van Wijk R Pignatti P Quirce S Sastre J Toskala E Vandenplas O Walusiak-Skorupa J Malo J L .EAACI Position Paper on assessment of cough in the workplace.Allergy. 2014 Mar;69(3):292-304. doi: 10.1111/all.12352. Epub 2014 Jan 15. Review..PudMed PMID:24428394

2.

Vandenplas O, Suojalehto H, Aasen TB, Baur X, Burge PS, de Blay F, Fishwick D, Hoyle J, Maestrelli P, Muñoz X, Moscato G, Sastre J, Sigsgaard T, Suuronen K, Walusiak-Skorupa J, Cullinan P, ERS Task Force on Specific Inhalation Challenges with Occupational Agents.Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement.Eur Respir J. 2014 Jun;43(6):1573-87. doi: 10.1183/09031936.00180313. Epub 2014 Mar 6..PudMed PMID:24603815

3.

Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, Piacentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O.Current evidence and future research needs for FeNO measurement in respiratory diseases.Respir Med. 2014 Jun;108(6):830-41. doi: 10.1016/j.rmed.2014.02.005. Epub 2014 Feb 15. Review..PudMed PMID:24636813

4.

Ma Paz Zafra, Mazzeo C, Gámez C, Rodriguez Marco A, de Zulueta A, Sanz V, Bilbao I, Ruiz-Cabello J, Zubeldia JM, Pozo VD.Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in mice.PLoS One. 2014;9(3):e91996. doi: 10.1371/journal.pone.0091996. Erratum in: PLoS One. 2014;9(8):e105924. .PudMed PMID:24637581

5.

Gandolfo-Cano M Bartra J González-Mancebo E Feo-Brito F Gómez E Bartolomé B Muñoz-García E Sanz Maroto A Vivanco F Cuesta-Herranz J Pastor-Vargas C .Molecular characterization of contact urticaria in patients with melon allergy.Br J Dermatol. 2014 Mar;170(3):651-6. doi: 10.1111/bjd.12701..PudMed PMID:24640940

6.

Rojas Pérez-Ezquerra P, Sánchez-Morillas L, Davila-Ferandez G, Ruiz-Hornillos FJ, Carrasco García I, Herranz Mañas M, Laguna Martínez JJ, Bartolomé B.Contact urticaria to Cannabis sativa due to a lipid transfer protein (LTP).Allergol Immunopathol (Madr). 2015 Mar-Apr;43(2):231-3. doi: 10.1016/j.aller.2013.10.002. Epub 2014 Mar 20. .PudMed PMID:24657136

7.

Yucesoy B, Johnson VJ, Lummus ZL, Kashon ML, Rao M, Bannerman-Thompson H, Frye B, Wang W, Gautrin D, Cartier A, Boulet LP, Sastre J, Quirce S, Tarlo SM, Germolec DR, Luster MI, Bernstein DI.Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma.J Occup Environ Med. 2014 Apr;56(4):382-7. doi: 10.1097/JOM.0000000000000138..PudMed PMID:24709764

8.

López-Cacho JM, Gallardo S, Posada M, Aguerri M, Calzada D, Mayayo T, González-Rodríguez ML, Rabasco AM, Lahoz C, Cárdaba B.Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.Biomed Res Int. 2014;2014:148293. doi: 10.1155/2014/148293. Epub 2014 Apr 10..PudMed PMID:24818126

9.

Haroun-Díaz E, Ruíz-García M, De Luxán de la Lastra S, Pastor-Vargas C, De las Heras M, Sastre Domínguez J, Cuesta-Herranz J.Contact dermatitis to both tropicamide and phenylephrine eye drops.Dermatitis. 2014 May-Jun;25(3):149-50. doi: 10.1097/DER.0000000000000043. .PudMed PMID:24819290

10.

Jáuregui I Ortiz de Frutos F J Ferrer M Giménez-Arnau A Sastre J Bartra J Labrador M Silvestre J F Valero A .Assessment of severity and quality of life in chronic urticaria.J Investig Allergol Clin Immunol. 2014;24(2):80-6. Review..PudMed PMID:24834770

11.

Vandenplas O Wiszniewska M Raulf M de Blay F Gerth van Wijk R Moscato G Nemery B Pala G Quirce S Sastre J Schlünssen V Sigsgaard T Siracusa A Tarlo S M van Kampen V Zock J-P Walusiak-Skorupa J .EAACI position paper: irritant-induced asthma.Allergy. 2014 Sep;69(9):1141-53. doi: 10.1111/all.12448. Epub 2014 Jul 5..PudMed PMID:24854136

12.

González-Mancebo E, Gandolfo-Cano M, González-de-Olano D, Mohedano-Vicente E, Bartolome B, Pastor-Vargas C.Identification of a novel protein allergen in Mediterranean silverside fish species.Ann Allergy Asthma Immunol. 2014 Jul;113(1):114-5. doi: 10.1016/j.anai.2014.04.025. Epub 2014 May 23. .PudMed PMID:24863400

13.

Martin-Lorenzo M, Gonzalez-Calero L, Zubiri I, Diaz-Payno PJ, Sanz-Maroto A, Posada-Ayala M, Ortiz A, Vivanco F, Alvarez-Llamas G.Urine 2DE proteome analysis in healthy condition and kidney disease.Electrophoresis. 2014 Sep;35(18):2634-41. doi: 10.1002/elps.201300601. Epub 2014 Aug 14..PudMed PMID:24913465

14.

Garrido-Arandia M, Murua-García A, Palacin A, Tordesillas L, Gómez-Casado C, Blanca-Lopez N, Ramos T, Canto G, Blanco C, Cuesta-Herranz J, Sánchez-Monge R, Pacios LF, Díaz Perales A.The role of N-glycosylation in kiwi allergy.Food Sci Nutr. 2014 May;2(3):260-71. doi: 10.1002/fsn3.99. Epub 2014 Mar 19..PudMed PMID:24936296

15.

Martin-Lorenzo M, Balluff B, Sanz-Maroto A, van Zeijl RJ, Vivanco F, Alvarez-Llamas G, McDonnell LA.30μm spatial resolution protein MALDI MSI: In-depth comparison of five sample preparation protocols applied to human healthy and atherosclerotic arteries.J Proteomics. 2014 Aug 28;108:465-8. doi: 10.1016/j.jprot.2014.06.013. Epub 2014 Jun 25..PudMed PMID:24972319

16.

Gámez C, Zafra MP, Boquete M, Sanz V, Mazzeo C, Ibáñez MD, Sánchez-García S, Sastre J, Del Pozo V.New shrimp IgE-binding proteins involved in mite-seafood cross-reactivity.Mol Nutr Food Res. 2014 Sep;58(9):1915-25. doi: 10.1002/mnfr.201400122. Epub 2014 Jun 30..PudMed PMID:24978201

17.

Sirvent S, Cantó B, Cuesta-Herranz J, Gómez F, Blanca N, Canto G, Blanca M, Rodríguez R, Villalba M, Palomares O.Act d 12 and Act d 13: two novel, masked, relevant allergens in kiwifruit seeds.J Allergy Clin Immunol. 2014 Jun;133(6):1765-7.e4. doi: 10.1016/j.jaci.2014.01.035. Epub 2014 Mar 21. .PudMed PMID:24990823

18.

Torres JA, de Las Heras M, Maroto AS, Vivanco F, Sastre J, Pastor-Vargas C.Molecular and immunological characterization of the first allergenic lipocalin in hamster: the major allergen from Siberian hamster (Phodopus sungorus).J Biol Chem. 2014 Aug 22;289(34):23382-8. doi: 10.1074/jbc.M114.579060. Epub 2014 Jul 3..PudMed PMID:24993820

19.

Azofra J, Maroto AS, Vivanco F, Pastor-Vargas C.Angler fish is not an alternative in allergy to multiple fish species.Ann Allergy Asthma Immunol. 2014 Sep;113(3):323-4. doi: 10.1016/j.anai.2014.06.008. Epub 2014 Jul 1. .PudMed PMID:24996993

20.

Dávila I, Navarro A, Domínguez-Ortega J, Alonso A, Antolín-Amérigo D, Diéguez MC, González-Mancebo E, Martíns C, Martínez C, Núñez B, Prior N, Rechel M, Rosado A, Ruiz-Hornillos J, Sansosti A, Torrecillas M, Jerez MJ; QUASAR Group; QUality Administration of SLIT in Allergic Rhinitis..SLIT: indications, follow-up, and management.J Investig Allergol Clin Immunol. 2014;24 Suppl 1:1-35..PudMed PMID:25011377

21.

Manso L, Valbuena T, Padial MA, Reche M, Zafra MP, Del Pozo V, Pascual CY.Allergy to short-acting β2-agonists in a COPD patient: Is an immunological mechanism involved?Allergol Immunopathol (Madr). 2015 May-Jun;43(3):329-330. doi: 10.1016/j.aller.2014.04.003. Epub 2014 Aug 3. .PudMed PMID:25097024

22.

Moscato G, Pala G, Sastre J.Specific immunotherapy and biological treatments for occupational allergy.Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):576-81. doi: 10.1097/ACI.0000000000000105..PudMed PMID:25115685

23.

Munoz X, Viladrich M, Manso L, del Pozo V, Quirce S, Cruz MJ, Carmona F, Sánchez-Pla A, Sastre J.Evolution of occupational asthma: does cessation of exposure really improve prognosis?Respir Med. 2014 Sep;108(9):1363-70. doi: 10.1016/j.rmed.2014.08.001. Epub 2014 Aug 14..PudMed PMID:25160572

24.

Lobera Labairu T González Mahave I Del Pozo Gil M D Venturini Díaz M Blasco Sarramián A Pastor-Vargas C Vivanco F Bartolomé Zavala B .Occupational rhinitis due to inhalation of chicken meat protein.J Investig Allergol Clin Immunol. 2014;24(4):278-9. .PudMed PMID:25219114

25.

Guillen Daiana Fiandor Ana Del Pozo Victoria Pedrosa María Phillips-Angles Elsa Caballero Teresa Quirce Santiago .Anaphylaxis caused by hemocyanin contained in shrimp cephalothorax.Ann Allergy Asthma Immunol. 2014 Dec;113(6):674-675.e2. doi: 10.1016/j.anai.2014.09.011. Epub 2014 Oct 11. .PudMed PMID:25308854

26.

Domínguez-Soto Angeles de Las Casas-Engel Mateo Bragado Rafael Medina-Echeverz José Aragoneses-Fenoll Laura Martín-Gayo Enrique van Rooijen Nico Berraondo Pedro Toribio María L Moro María A Cuartero Isabel Castrillo Antonio Sancho David Sánchez-Torres Carmen Bruhns Pierre Sánchez-Ramón Silvia Corbí Angel L .Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization.J Immunol. 2014 Nov 15;193(10):5181-9. doi: 10.4049/jimmunol.1303375. Epub 2014 Oct 17..PudMed PMID:25326025

27.

Gonzalez-Calero Laura Martin-Lorenzo Marta Alvarez-Llamas Gloria .Exosomes: a potential key target in cardio-renal syndrome.Front Immunol. 2014;5:465. doi: 10.3389/fimmu.2014.00465. Review..PudMed PMID:25339951

28.

Gil-Bona Ana Llama-Palacios Arancha Parra Claudia Marcela Vivanco Fernando Nombela César Monteoliva Lucía Gil Concha .Proteomics unravels extracellular vesicles as carriers of classical cytoplasmic proteins in Candida albicans.J Proteome Res. 2015 Jan 2;14(1):142-53. doi: 10.1021/pr5007944. Epub 2014 Nov 12..PudMed PMID:25367658

29.

Ferrer M Bartra J Giménez-Arnau A Jauregui I Labrador-Horrillo M de Frutos J Ortiz Silvestre Jf Sastre J Velasco M Valero A .Management of urticaria: not too complicated, not too simple.Clin Exp Allergy. 2015 Apr;45(4):731-43. doi: 10.1111/cea.12465..PudMed PMID:25429900

30.

Blanca Cárdaba,1,2 David Calzada,1 Selene Baos,1 Miriam Aguerri,1 Joaquín Quiralte,3 and Carlos Lahoz.Polymorphisms of Tumor Necrosis Factor-?, Transforming Growth Factor-?, and Interleukin-10 in Asthma Associated with Olive Pollen SensitizationJournal of Immunology Research2014.PudMed PMID:0

31.

Laborde CM, Mourino-Alvarez L, Posada-Ayala M, Alvarez-Llamas G, Serranillos-Reus MG, Moreu J, Vivanco F, Padial LR, Barderas MG..Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndromeMetabolomics2014.PudMed PMID:0

32.

Laborde CM, Alonso-Orgaz S, Mourino-Alvarez L, Moreu J, Vivanco F, Padial LR, Barderas MG.The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndromeProteome Science2014.PudMed PMID:0

33.

Marta Martin-Lorenzo, Irene Zubiri, Aroa S. Maroto, Laura Gonzalez-Calero, Maria Posada-Ayala, Fernando de la Cuesta, Laura Mourino-Alvarez, Luis F Lopez-Almodovar, Eva Calvo-Bonacho, Luis M Ruilope, Luis R Padial, Maria G Barderas, Fernando Vivanco, Gloria Alvarez-Llamas.KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recoveryMetabolomics2014.PudMed PMID:0

34.

Sastre J, Poltronieri A, Mahillo-Fernandez I, Aguado E, García Del Potro M, Fernandez-Nieto M..Nasal response in patients with diisocyanate asthma.Rhinology. 2014 Dec;52(4):431-6. doi: 10.4193/Rhin14.005..PudMed PMID:25479228

35.

Arochena L, Fernández-Nieto M, Aguado E, García del Potro M, Sastre J.Eosinophilic bronchitis caused by styrene.J Investig Allergol Clin Immunol. 2014;24(1):68-9. No abstract available. .PudMed PMID:24765888

36.

Laborde CM, Alonso-Orgaz S, Mourino-Alvarez L, Moreu J, Vivanco F, Padial LR, Barderas MG..The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome.Proteome Sci. 2014;12:43. doi: 10.1186/1477-5956-12-43..PudMed PMID:26038678

37.

Laborde CM, Mourino-Alvarez L, Posada-Ayala M, Alvarez-Llamas G, Serranillos-Reus MG, Moreu J, Vivanco F, Padial LR, Barderas MG..Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome.Metabolomics. 2014;10(3):414-424. Epub 2013 Oct 26..PudMed PMID:25814918

38.

Blanca Cárdaba, David Calzada, Selene Baos, Miriam Aguerri, Joaquín Quiralte, and Carlos Lahoz.Polymorphisms of tumor necrosis factor-α, transforming growth factor-β, and interleukin-10 in asthma associated with olive pollen sensitization.J Immunol Res. 2014;2014:276345. doi: 10.1155/2014/276345. Epub 2014 Dec 21..PudMed PMID:25759826



Projects (2013)

1. "Caracterización de perfiles génicos discriminatorios de sensibilidad y tolerancia: Alergia respiratoria"

Investigadora Principal Dra. B. Cárdaba Olombrada.

Proyecto Público Competitivo PI10/00025.

2. "Desarrollo de métodos mejorados para la detección de alérgenos ocultos en diferentes fuentes. Aplicación en estudios de sensibilización temprana en recién nacidos"

Investigador Principal Dr. J. Cuesta Herranz.

Proyecto Público Competitivo PI10/00974.

3. "Red temática de investigación cooperativa de reacciones adversas a alérgenos y fármacos en España (RIRAAF)"

Investigador Principal Dr. J. Cuesta Herranz.

Proyecto Público Competitivo RD12/0013/0013.

4."Regulación epigenética del asma: Papel de los microRNA´s ySOCS"

Investigadora Principal Dra. V. del Pozo Abejón.

Proyecto Público Competitivo PI12/00691.

5."Diseño de nuevas formas farmacéuticas para administración de inmunoterapia oral para el tratamiento de alergia alimentaria al cacahuete"

Investigadora Principal Dra. V. del Pozo Abejón.

Financiación Privada 5255/001.

6."Grupo de investigación CIBER en enfermedades respiratorias"

Investigadora Principal Dra. V. del Pozo Abejón.

Proyecto Público Competitivo CIBERES.

7. "Centers of excellence Project in respiratory allergy"

Investigador Principal Dr. J. Sastre Domínguez.

Financiación Privada 4216/006.

8. "Administración subcutánea en infusión continua en el tratamiento de la enfermedad alérgica respiratoria inducida por el epitelio en animales"

Investigador Principal Dr. J. Sastre Domínguez.

Financiación Privada 4216/002.

9. "Nuevos abordajes proteómicos y metobolómicos en el estudio de la evolución de órganos diana en pacientes hipertensos tratados con bloqueantes del sistema Renina-Angiotensina"

Investigador Principal Dr. F. Vivanco Martínez.

Proyecto Público Competitivo PI11/01401.


Clinical trials and Observational studies (2013)

1. Clinical trial "Estudio Pivotal aleatorizado, doble ciego o/y controlado con placebo para evaluar la eficacia y la seguridad de rPHLEUM en pacientes adultos y adolescentes que padecen rinoconjuntivitis +/- asma controlada"

(NºEUDRACT: 2009-011504-36. Clinical trial Fase III Multicéntrico Internacional). Investigador Principal: J. Cuesta Herranz.

2. Clinical trial "Clinical trial multicéntrico, abierto, para la comparación de la potencia biológica entre los extractos alergénicos nativo, despigmentado y despigmentado polimerizado de epitelio de gato" (NºEUDRACT: 2012-001931-30. Clinical trial Fase II Multicéntrico). Investigador Principal: J. Sastre Domínguez.

3. Observational studies "Efectividad y adherencia de un extracto alergoide de alta dosis (ALLERGOVIT ®): seguimiento durante 2 años de tratamiento". Ref. 4091/001Investigador Principal: J. Cuesta Herranz.

4. Observational studies "Efectividad y adherencia de un extracto alergoide de alta dosis (ACAROID ®): seguimiento durante 2 años de tratamiento". Ref. 4091/002 Investigador Principal: J. Cuesta Herranz.

5. Observational studies "Uso de OLIMALIZUMAB en la práctica clínica real en España tras 5 años de experiencia. Estudio Expert 5". Ref. 4216/005 Investigador Principal: J. Sastre Domínguez.


Patentes

- P201330663 "Procedimiento de diagnóstico y pronóstico de la enfermedad renal crónica en un sujeto humano"

-P20143090 "Desarrollo de un método optimizado para la detección y la cuantificación de la presencia de alérgenos de mostaza en alimentos"